Results 111 to 120 of about 2,855 (178)

Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression

JACS Au, 2023
Hailing Chen, Meimiao Zhan, Yaping Zhang, Jianbo Liu, Rui Wang, Yuhao An, Zhanxia Gao, Leying Jiang, Yun Xing, Yibin Kang, Zigang Li, Feng Yin   +11 more
doaj   +1 more source

PARG inhibition suppresses breast cancer progression and potentiates immunoresponse through MTDH degradation mediated by E3 ligase ITCH-dependent ubiquitination. [PDF]

NPJ Breast Cancer
Wang J, Dong Y, Lun W, Nai M, Shi Y, Geng J, Cai W, Liu J, Li H, Li L.   +9 more
europepmc   +1 more source

SND1, a novel m6A RNA regulator: Its high expression correlates with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. [PDF]

J Oral Biol Craniofac Res
Gopalakrishnan K, Pandi C, Jayaseelan VP, Arumugam P.   +3 more
europepmc   +1 more source

Exploring the role of the arginine-methylation writer-reader pair PRMT5/SND1 in JAK2-mutant myeloproliferative neoplasms

Myeloproliferative neoplasms (MPNs) are a hematopoietic disease characterized by hyperproliferation of cells of the myeloid lineage for which current therapeutic options are limited.
Rubiano, Rocio
core   +1 more source

Transcriptional regulation of thorn tip sclerification in plants. [PDF]

Proc Natl Acad Sci U S A
Ren J, Duan Y, Li R, Zhang X, Shi Y, Zhou S, Xie K, Wu X, Irish VF, Deng X, Zhang F, Guo W.   +11 more
europepmc   +1 more source

Corrigendum: miRNA-296-5p functions as a potential tumor suppressor in human osteosarcoma by targeting SND1

Chinese Medical Journal, 2021
doaj   +1 more source

Correction: Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling

Journal of Experimental & Clinical Cancer Research, 2022
Binghong Chen, Mengying Wang, Junjun Qiu, Keman Liao, Wenrui Zhang, Qi Lv, Chunhui Ma, Zhongrun Qian, Zhonggang Shi, Rong Liang, Yan Lin, Jiazhou Ye, Yongming Qiu, Yingying Lin   +13 more
doaj   +1 more source

Identification of unique biomarkers in colorectal cancer based on comprehensive analysis and machine learning. [PDF]

Front Oncol
Wang L, Ren A, Cui X, Shen Y, Huang Q.
europepmc   +1 more source

Staphylococcal nuclease and tudor domain-containing protein 1: An emerging therapeutic target in cancer (Review). [PDF]

Mol Clin Oncol
Rai SK, Khan MI, Kumar R, Patil RI, Dhawan S, Panwar A, Kumar A.   +6 more
europepmc   +1 more source

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer. [PDF]

Adv Sci (Weinh)
Sang Y, Liu S, Zhou X, Chi W, Xiong M, Chen M, Ren H, Liu D, Zhang L, Xue J, Chi Y, Wu J.   +11 more
europepmc   +1 more source